Cargando...
Ticagrelor-Induced Prolongation of the QTc Interval
BACKGROUND: Ticagrelor has been accepted as a class I antiplatelet agent in patients undergoing percutaneous coronary angioplasty (PTCA). There have been cases reported on ticagrelor being associated with various cardiac conduction defects. But there is no evidence of QTc prolongation associated wit...
Gardado en:
| Publicado en: | Case Rep Cardiol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Hindawi
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6881594/ https://ncbi.nlm.nih.gov/pubmed/31827937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5984847 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|